Starling Oncology (STLNW) Profit After Tax Growth (1y) (2021 - 2026)
Powered by 
Analysis
Starling Oncology (STLNW) Profit After Tax Growth (1y) (2021 - 2026) Analysis & Trends
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | PAT Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Davita | 11.90 Bn | 11.21 Bn | 1.16 Bn | 24.71% |
| 2 | RadNet | 5.52 Bn | 4.79 Bn | 88.08 Mn | -12.07% |
| 3 | Fresenius Medical Care AG | 4.79 Bn | 4.09 Bn | 1.52 Bn | 10.56% |
| 4 | Concentra Group Holdings Parent | 4.28 Bn | 4.12 Bn | 192.10 Mn | 45.69% |
| 5 | Privia Health | 2.57 Bn | 2.16 Bn | - | 196.05% |
| 6 | Pediatrix Medical | 2.15 Bn | 1.74 Bn | - | 0.39% |
| 7 | Progyny | 2.12 Bn | 1.89 Bn | 89.30 Mn | 63.93% |
| 8 | Surgery Partners | 1.82 Bn | 1.61 Bn | 622.10 Mn | -33.85% |
| 9 | U S Physical Therapy | 1.17 Bn | 1.14 Bn | 41.94 Mn | -15.93% |
| 10 | Starling Oncology | 4.13 Mn | -36.96 Mn | 27.17 Mn | 42.45% |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 42.45% |
| Mar 31, 2026 | 87.28% |
| Dec 31, 2025 | 43.04% |
| Sep 30, 2025 | -2.43% |
| Jun 30, 2025 | -9.88% |
| Mar 31, 2025 | 1.53% |
| Dec 31, 2024 | 29.71% |
| Sep 30, 2024 | 7.50% |
| Jun 30, 2024 | 8.39% |
| Mar 31, 2024 | 33.70% |
| Dec 31, 2023 | 33.35% |
| Sep 30, 2023 | -551.42% |
| Jun 30, 2023 | -209.87% |
| Mar 31, 2023 | -255.54% |
| Dec 31, 2022 | -177.07% |
| Sep 30, 2022 | 10.27% |
| Jun 30, 2022 | -270.14% |
| Mar 31, 2022 | 2,036.35% |
| Dec 31, 2021 | -253,899,900.00% |
| Sep 30, 2021 | -23.31% |